Retreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir + Ribavirin for Hepatitis C Virus Genotype 4 Patients. [electronic resource]
Producer: 20180522Description: 1341-1347 p. digitalISSN:- 1573-2568
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Retreatment
- Ribavirin -- therapeutic use
- Ritonavir -- therapeutic use
- Sofosbuvir -- therapeutic use
- Sulfonamides
- Sustained Virologic Response
- Treatment Outcome
- Valine
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.